Rydex Health Care Inv (RYHIX) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.00: the stock has moved roughly in step with the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerRydex Health Care Inv (RYHIX) trades at $152.90. Rydex Health Care Inv (RYHIX) is a mutual fund focused on investing in equity securities of U.S.-traded healthcare companies.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for RYHIX: RYHIX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Rydex Health Care Inv Company Overview
Rydex Health Care Inv (RYHIX) is a mutual fund concentrating on U.S.-traded healthcare companies, employing derivatives and potentially investing in small to mid-sized firms and ADRs. With a beta of 1.00 and no dividend yield, RYHIX offers exposure to the healthcare sector, appealing to investors seeking capital appreciation.
What Is the Investment Thesis for RYHIX?
Rydex Health Care Inv (RYHIX) presents an investment opportunity for those seeking exposure to the healthcare sector through a diversified fund. The fund's strategy of investing in U.S.-traded healthcare companies, coupled with the use of derivatives, aims to enhance returns. The potential investment in small to mid-sized companies offers additional growth opportunities. However, the fund's performance is subject to the inherent risks of the healthcare sector, including regulatory changes and market volatility. With a beta of 1.00, RYHIX exhibits market-correlated volatility. Investors may want to evaluate their risk tolerance and investment objectives before investing in RYHIX. The absence of a dividend yield indicates that the fund's primary focus is on capital appreciation rather than income generation.
Based on FMP financials and quantitative analysis
RYHIX Key Highlights
RYHIX invests at least 80% of its net assets in equity securities of Health Care Companies traded in the United States.
- The fund uses derivatives, including futures contracts and options, to manage risk and potentially enhance returns.
- RYHIX may invest in small to mid-sized Health Care Companies, offering exposure to growth opportunities.
- The fund can purchase American Depositary Receipts (ADRs) to gain exposure to foreign Health Care Companies.
- RYHIX has a beta of 1.00, indicating market-correlated volatility.
Who Are RYHIX's Competitors?
RYHIX is benchmarked below against 5 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| EQCHX AXS Chesapeake Strategy Fund Class I | $9.74 | +0.10% | $13.8M | — |
| GIGRX Gabelli International Growth Fund, Inc. Class AAA | $24.96 | +0.69% | $19.4M | — |
| GOPIX Aberdeen China A Share Equity Fund Institutional Class | $27.31 | 0.00% | $17.1M | — |
| JMCGX Jacob Discovery Fund Investor Class | $29.76 | -0.03% | $19.7M | — |
| MJSC MUFG Japan Small Cap Active ETF | $62.54 | -0.22% | $21.7M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RYHIX's Key Strengths?
Diversified exposure to the healthcare sector.
- Use of derivatives for risk management and potential return enhancement.
- Potential for growth through investments in small to mid-sized companies.
- Access to foreign healthcare companies through ADRs.
What Are RYHIX's Weaknesses?
Reliance on the performance of the healthcare sector.
- Potential for losses due to the use of derivatives.
- Vulnerability to regulatory changes in the healthcare industry.
- Lack of dividend yield may deter income-seeking investors.
What Are the Key Risks for RYHIX?
Economic downturns could reduce healthcare spending and negatively impact the fund's performance.
- Increased competition from other healthcare-focused funds could erode market share.
- Regulatory changes in the healthcare industry could adversely affect the fund's investments.
- The fund's use of derivatives could lead to losses in unfavorable market conditions.
- Changes in healthcare policy and reimbursement models.
What Are RYHIX's Competitive Advantages?
- Expertise in healthcare sector investing.
- Access to a wide range of healthcare companies through U.S. markets and ADRs.
- Use of derivatives for risk management and potential return enhancement.
- Established track record in managing healthcare-focused investments.
What Does RYHIX Do?
Rydex Health Care Inv (RYHIX) is a mutual fund designed to provide investors with exposure to the healthcare sector. The fund operates by investing primarily in the equity securities of healthcare companies that are traded in the United States. A significant portion, at least 80% of its net assets, is allocated to these investments. To enhance its investment strategies, RYHIX utilizes derivatives, which include futures contracts and options on securities, futures contracts, and stock indices. This allows the fund to potentially amplify returns and manage risk. In addition to large-cap healthcare companies, RYHIX may also invest in the securities of healthcare companies with small to mid-sized capitalizations, broadening its investment scope within the sector. The fund also has the flexibility to purchase American Depositary Receipts (ADRs) to gain exposure to foreign healthcare companies, further diversifying its portfolio. RYHIX aims to provide investors with a comprehensive investment vehicle for participating in the growth and performance of the healthcare industry.
What Products and Services Does RYHIX Offer?
- Invests primarily in equity securities of U.S.-traded healthcare companies.
- Utilizes derivatives such as futures contracts and options.
- May invest in small to mid-sized healthcare companies.
- Purchases American Depositary Receipts (ADRs) to gain exposure to foreign healthcare companies.
- Aims to provide investors with exposure to the healthcare sector.
- Manages a portfolio of healthcare-related investments.
How Does RYHIX Make Money?
- Generates returns through capital appreciation of its investments.
- Utilizes derivatives to potentially enhance returns and manage risk.
- Collects management fees based on the assets under management (AUM).
- Reinvests dividends and capital gains to maximize long-term growth.
What Industry Does RYHIX Operate In?
Rydex Health Care Inv (RYHIX) operates within the healthcare sector, which is influenced by factors such as technological advancements, regulatory changes, and demographic shifts. The healthcare industry is characterized by both growth opportunities and inherent risks. The fund's investment strategy aligns with the overall trends in the healthcare sector, including the increasing demand for healthcare services and the development of new medical technologies. The competitive landscape includes other healthcare-focused mutual funds and ETFs, each with its own investment strategy and risk profile.
Who Are RYHIX's Key Customers?
- Individual investors seeking exposure to the healthcare sector.
- Institutional investors looking for diversified healthcare investments.
- Retirement savers seeking long-term growth opportunities.
- Financial advisors seeking to provide healthcare investment options to their clients.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 41 snapshots
| 2026-08-23 | 44 |
| 2026-08-31 | 44 |
| 2026-09-08 | 44 |
| 2026-09-16 | 44 |
| 2026-09-24 | 44 |
| 2026-10-04 | 44 |
What changed?
The score has stayed at 44.
Over the same 30 days the stock moved -4.0%.
RYHIX Financials
Bull Case vs Bear Case
Bull Case
- Diversified exposure to the healthcare sector.
- Use of derivatives for risk management and potential return enhancement.
- Potential for growth through investments in small to mid-sized companies.
- Access to foreign healthcare companies through ADRs.
Bear Case
- Reliance on the performance of the healthcare sector.
- Potential for losses due to the use of derivatives.
- Vulnerability to regulatory changes in the healthcare industry.
- Lack of dividend yield may deter income-seeking investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
RYHIX Latest News
No recent news available for RYHIX.
RYHIX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for RYHIX.
Price Targets
Wall Street price target analysis for RYHIX.
RYHIX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for RYHIX; grades run from A+ (80-100) to F (below 30).
Common Questions About RYHIX
What do analysts say about RYHIX stock?
Key valuation metrics to consider include the fund's net asset value (NAV), expense ratio, and historical performance relative to its benchmark.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The healthcare sector is subject to regulatory changes and technological disruptions.